Literature DB >> 21364193

CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow.

Giuseppe Sciumè1, Giulia De Angelis, Giorgia Benigni, Andrea Ponzetta, Stefania Morrone, Angela Santoni, Giovanni Bernardini.   

Abstract

During development in the bone marrow (BM), NK-cell positioning within specific niches can be influenced by expression of chemokine or adhesion receptors. We previously demonstrated that the maintenance in the BM of selected NK-cell subsets is regulated by the CXCR4/CXCL12 axis. In the present study, we showed that CX3CR1 is prevalently expressed on KLRG1(+) NK cells, a subset considered terminally differentiated. Two KLRG1(+) NK-cell populations endowed with distinct homing and functional features were defined according to CX3CR1 expression. In the BM, KLRG1(+)/CX3CR1(-) NK cells were mainly positioned into parenchyma, while KLRG1(+)/CX3CR1(+) NK cells exhibited reduced CXCR4 expression and were preferentially localized in the sinusoids. We also showed that α(4) integrin plays a pivotal role in the maintenance of NK cells in the BM sinusoids and that α(4) neutralization leads to strong reduction of BM KLRG1(+)/CX3CR1(+) NK cells. Moreover, we found that KLRG1(+)/CX3CR1(+) cells originate from KLRG1(+)/CX3CR1(-) NK-cell population and display impaired capability to produce IFN-γ and to lyse YAC-1 target cells on cytokine stimulation. Altogether, our findings show that CX3CR1 represents a marker of a KLRG1(+) NK-cell population with unique properties that can irreversibly differentiate from the KLRG1(+)/CX3CR1(-) NK cells during steady state conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21364193     DOI: 10.1182/blood-2010-07-297101

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

Review 1.  NK cell trafficking in health and autoimmunity:a comprehensive review.

Authors:  Hui Peng; Zhigang Tian
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 2.  Bone specific immunity and its impact on metastasis.

Authors:  Nikola Baschuk; Jay Rautela; Belinda S Parker
Journal:  Bonekey Rep       Date:  2015-04-15

3.  Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.

Authors:  Helena Stabile; Paolo Nisti; Stefania Morrone; Daria Pagliara; Alice Bertaina; Franco Locatelli; Angela Santoni; Angela Gismondi
Journal:  Haematologica       Date:  2015-01-16       Impact factor: 9.941

Review 4.  Natural killer cell homing and trafficking in tissues and tumors: from biology to application.

Authors:  Guang He Ran; Yu Qing Lin; Lei Tian; Tao Zhang; Dong Mei Yan; Jian Hua Yu; You Cai Deng
Journal:  Signal Transduct Target Ther       Date:  2022-06-29

5.  Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii.

Authors:  Lucas Souza Ferreira; Deivys Leandro Portuondo; Marisa Campos Polesi; Iracilda Zeppone Carlos
Journal:  Immunology       Date:  2018-08-14       Impact factor: 7.397

6.  A VEGFR-3 antagonist increases IFN-γ expression on low functioning NK cells in acute myeloid leukemia.

Authors:  Ji Yoon Lee; Sohye Park; Donghyun Curt Kim; Jae-Ho Yoon; Seung Hwan Shin; Woo-Sung Min; Hee-Je Kim
Journal:  J Clin Immunol       Date:  2013-02-13       Impact factor: 8.317

7.  CCR2 defines a distinct population of NK cells and mediates their migration during influenza virus infection in mice.

Authors:  Mary J G van Helden; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

Review 8.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

9.  Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow.

Authors:  Giovanni Bernardini; Giuseppe Sciumè; Angela Santoni
Journal:  Front Immunol       Date:  2013-01-30       Impact factor: 7.561

10.  Distinct requirements for T-bet in gut innate lymphoid cells.

Authors:  Giuseppe Sciumé; Kiyoshi Hirahara; Hayato Takahashi; Arian Laurence; Alejandro V Villarino; Kentner L Singleton; Sean P Spencer; Christoph Wilhelm; Amanda C Poholek; Golnaz Vahedi; Yuka Kanno; Yasmine Belkaid; John J O'Shea
Journal:  J Exp Med       Date:  2012-12-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.